The invention relates to triamide MTP/ApoB inhibitors of the formula 1 1
wherein R.sup.1--R.sup.8 are as defined in the specification, as well as
pharmaceutical compositions and uses thereof, and processes for preparing
the compounds. The compounds of the invention are useful for the
treatment of obesity and lipid disorders.
